https://apnews.com/1e87ce13a62186dc4e5a7719ba8a6954 > PARIS — Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they launched a large Phase III trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin America. > The study will test the effectiveness of vaccine candidate formulas against the virus that spread from Wuhan, China, and against a variant first seen in South Africa, the pharmaceutical firms said.